With one woman in Australia dying every eight hours from ovarian cancer, the urgency to address the unmet clinical need in cancer therapeutics has never been more paramount. A significant manufacturing agreement between OncoTEX Inc. (OncoTEX) and Sterling Pharma Solutions will see the production of novel platinum-resistant cancer-fighting drug, OxaliTEX, scaled up for preclinical and […]

NEW YORK APRIL 15, 2021 — GBS, Inc. (GBS), a life sciences company developing non-invasive, real-time point-of-care (POC) diagnostic tests, and the Wyss Institute for Biologically Inspired Engineering at Harvard University (Wyss Institute) have received approval from the Harvard Longwood campus Institutional Review Board (IRB) to commence a validation study to test clinical samples from […]

A pre-clinical platinum-resistant cancer-fighting drug candidate that localises to tumour cells is granted a patent in Australia. OxaliTEX is being developed in Texas by US oncology company, OncoTEX Inc (OncoTEX), a member of Australian bioscience enterprise The iQ Group Global, from their oncology drug platform, TEX Core. TEX Core is a world-first oncology drug platform […]

Today marks a major milestone for The iQ Group Global with its 10th anniversary. What started as a bold vision to accelerate medical innovation by CEO and founder Dr George Syrmalis in 2011, has evolved into an internationally recognised bioscience investment consortium, championing a portfolio of world-first innovations in the fields of diagnostics and oncology. […]

With all eyes on the global rollout of lifesaving COVID-19 vaccines, we now know how swiftly unmet clinical needs can be achieved when indomitable minds work collectively. In January 2020, experts began analysing the novel SARS-CoV-2 virus spreading through the human populous after researchers in China uploaded gene sequencing data to a public portal. In […]

New York, NY, February 18, 2021 – GBS Inc. (Nasdaq: GBS), a life sciences company that develops non-invasive, real-time point of care (POC) diagnostic tests for patients and their primary health practitioners, today announced the execution of a sponsored research agreement with Johns Hopkins Bloomberg School of Public Health to accelerate development of next-generation saliva-based diagnostic tests. […]

Combination of the Wyss’ electrochemical sensing technology with GBS’s transistor technology could enable fast, multiplexed, low-cost COVID-19 biomarker analysis in point-of-care applications. This article has been republished with permission from the Wyss Institute at Harvard University. Click here to view the original article. By Benjamin Boettner (BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard […]

Vital research into children’s cancer has been bolstered through generous donations at the 2020 Tour de Cure Spring Lunch, with more than $1 million raised. Sponsored by presenting partner The iQ Group Global, the annual event received a raft of donations and support, with performances by Delta Goodrem, Matthew Copley and Prinnie Stevens. Channel Seven’s […]

The low-cost electrochemical technology for multiplexed biomarker detection could facilitate global serological testing for SARS-CoV-2 infections, and help trace immunity in individuals over time. This article has been republished with permission from the Wyss Institute at Harvard University. Click here to view the original article. By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for […]

As the number of people with diabetes continues to rise across the world, the role of nurses and other health professionals is crucial in managing the impact of the condition, the International Federation of Diabetes (IDF) urged this World Diabetes Day. With the theme ‘The Nurse and Diabetes’, the campaign on November 14 raised awareness of […]